The 20 Best Medullary Thyroid Carcinoma Doctors Near Me in Ypsilanti, MI

Nazanene H. Esfandiari, MD, is a Clinical Professor of Internal Medicine with an appointment in the Division of Metabolism, Endocrinology and Diabetes (MEND). Dr. Esfandiari received her medical degree from the University of Bordeaux in France, completed internal medicine residency in France and at UMASS Memorial Health Center in Massachusetts, and then completed fellowship in endocrinology at the University of Michigan. She joined the faculty at the University of Michigan in 2003. She was inducted into Clinical Excellence Society at the University of Michigan in 2014. She is the MEND Service Chief, Co-director of Hospital Intensive Insulin Program (HIIP) and Assistant Chief for the Inpatient Endocrine Consult.Dr. Esfandiari’s practice focuses on thyroid cancer, thyroid disorders, post bariatric care, and diabetes. She is also interested in medical education and is the Co-director of the Endocrine Sequence at the University of Michigan Medical School. In addition, Dr. Esfandiari has served in several national committees at the Endocrine Society and American Thyroid Association (ATA). Dr. Esfandiari is rated as a Distinguished provider by MediFind in the treatment of Medullary Thyroid Carcinoma. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Thyroid Cancer, Follicular Thyroid Cancer, Anaplastic Thyroid Cancer, Gastric Bypass, and Thyroidectomy. Dr. Esfandiari is board certified in Endocrinology, Diabetes & Metabolism.

Anuradha Puttagunta is an Endocrinologist practicing medicine in Ypsilanti, Michigan. Dr. Puttagunta is rated as an Advanced provider by MediFind in the treatment of Medullary Thyroid Carcinoma. She is also highly rated in 25 other conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), Thyroid Nodule, and Hypothyroidism.

Anita Repp is an Endocrinologist practicing medicine in Ypsilanti, Michigan. Dr. Repp is rated as an Advanced provider by MediFind in the treatment of Medullary Thyroid Carcinoma. She is also highly rated in 34 other conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Osteoporosis, Postmenopausal Osteoporosis, and Type 2 Diabetes (T2D).

Suma Amarnath is an Endocrinologist practicing medicine in Ypsilanti, Michigan. Dr. Amarnath is rated as an Advanced provider by MediFind in the treatment of Medullary Thyroid Carcinoma. She is also highly rated in 30 other conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Hyperthyroidism, Hypothyroidism, and Addison's Disease.

Ronald Koenig is an Endocrinologist practicing medicine in Ann Arbor, Michigan. Dr. Koenig is rated as a Distinguished provider by MediFind in the treatment of Medullary Thyroid Carcinoma. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Follicular Thyroid Cancer, Thyroid Cancer, Anaplastic Thyroid Cancer, Papillary Thyroid Cancer, and Thyroidectomy.

Dhammi Jayathilaka is an Endocrinologist practicing medicine in Ypsilanti, Michigan. Dr. Jayathilaka is rated as an Experienced provider by MediFind in the treatment of Medullary Thyroid Carcinoma. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Thyroid Storm, Thyroid Nodule, Hyperthyroidism, and Hyperparathyroidism.

Dr. Francis Worden received his medical degree from the Indiana University School of Medicine in 1993. Prior to attending medical school, he worked as a registered pharmacist at a large community hospital in Indianapolis. In 1997, Dr. Worden completed a combined residency in internal medicine and pediatrics at the Detroit Medical Center and finished a medical oncology/hematology fellowship at the University of Michigan. In July 2000, Dr. Worden joined the faculty at the University of Michigan Rogel Cancer Center, where he is currently working as a clinical investigator with both the multidisciplinary head and neck oncology team and the multidisciplinary lung cancer team. Dr. Worden's research interests include organ preservation in head and neck cancer and endocrine oncology. He is the Nancy Wigginton Oncology Research Professor of Thyroid Cancer. Avid competitive swimmer ; cyclist and runner. Dr. Worden is rated as a Distinguished provider by MediFind in the treatment of Medullary Thyroid Carcinoma. He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Throat Cancer, Thyroid Cancer, and Head and Neck Squamous Cell Carcinoma (HNSCC). Dr. Worden is board certified in Medical Oncology.

Megan R. Haymart, MD is Professor of Internal Medicine with an appointment in the Division of Metabolism, Endocrinology, and Diabetes at the University of Michigan. She holds the Nancy Wigginton Endocrinology Research Professorship of Thyroid Cancer and is Director of Thyroid Cancer Research at the University of Michigan. Dr. Haymart received her medical degree at Johns Hopkins University School of Medicine and completed her internal medicine residency at Johns Hopkins Hospital. She then completed a fellowship in endocrinology, diabetes, and metabolism at the University of Wisconsin. She has been faculty at the University of Michigan since 2009.Dr. Haymart has a history of NIH-funded research focused on optimizing thyroid care delivery. She is a health services researcher who primarily studies thyroid cancer care across the disease continuum: from the diagnosis of a thyroid nodule to cancer survivorship. In recognition of her research, she received the American Thyroid Association’s Van Meter Award for outstanding contributions to research on the thyroid gland (2017), the University of Michigan’s Jerome Conn Award for Research Excellence (2017), membership to American Society for Clinical Investigation (2018), the AACE Hossein Gharib Education Lectureship Award for exemplary contributions to an individual profession or area of expertise (2021), and the inaugural AACE Endocrine Care Innovation Award in recognition of her team’s outstanding body of work focused on clinical outcomes or health care delivery (2025).Dr. Haymart is actively involved in improving research infrastructure at the University of Michigan. This includes her roles as Assistant Director of Data Solutions for AI & Digital Health Innovation, faculty support for MICHR, and co-Director of Patient’s First. She also devotes time to mentoring junior faculty and trainees resulting in her receipt of the MICHR Distinguished Clinical and Translational Research Mentor Award (2021) and the Women in Thyroidology and American Thyroid Association Woman of the Year Award (2021) for promoting the advancement of women, both within the organization and field. Dr. Haymart is rated as an Advanced provider by MediFind in the treatment of Medullary Thyroid Carcinoma. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Thyroid Cancer, Thyroid Nodule, Papillary Thyroid Cancer, Thyroidectomy, and Hormone Replacement Therapy (HRT). Dr. Haymart is board certified in Endocrinology, Diabetes & Metabolism.

Maria Papaleontiou, MD, is an Associate Professor of Internal Medicine with an appointment in the Division of Metabolism, Endocrinology and Diabetes, and a Research Associate Professor at the Institute of Gerontology, at the University of Michigan. Prior to starting her internal medicine residency at Saint Peter's University Hospital in New Jersey, she spent several years conducting clinical research on aging at Weill Cornell Medical College in New York City. She completed her endocrinology fellowship at the University of Michigan, where she subsequently joined the faculty in 2013. She is a recipient of Fulbright and Howard Hughes Medical Institute scholarships. Her clinical practice focuses on thyroid diseases and thyroid cancer, as well as geriatric endocrinology.Dr. Papaleontiou is also a health services researcher in the field of thyroidology and aging. Her research focuses on evaluating the risks of thyroid hormone overtreatment and misuse in older adults, understanding the role of providers and patients in thyroid hormone use and misuse and how it relates to patient outcomes in the aging population, as well as the role of age and comorbidity in thyroid cancer decision-making. Her ultimate goal is to develop tools to tailor thyroid disease treatment to older adults by translating research findings into effective strategies and interventions to improve the care of older adults and reduce patient harm. She has received funding from the National Institute on Aging, the Claude D. Pepper Older American Independence Centers, the University of Michigan Biology of Cardiovascular Aging Core and the Elizabeth Caroline Crosby Research Award. She serves on multiple national committees including at the American Thyroid Association (ATA), the Endocrine Society, the American Association of Clinical Endocrinology and the North American Society for Interventional Thyroidology. She has served as Co-Chair for the ATA’s Annual Program Committee (2021-2022), Chair of the ATA’s Women in Thyroidology (2022-2023) and Vice-Chair for AACE's Thyroid Disease State Network (2022-2023). She is an Associate Editor for Endocrine Practice, and serves on the Editorial Boards for Thyroid and BMC Endocrine Disorders. Dr. Papaleontiou is rated as an Advanced provider by MediFind in the treatment of Medullary Thyroid Carcinoma. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Thyroid Cancer, Thyroid Nodule, Hypothyroidism, Thyroidectomy, and Hormone Replacement Therapy (HRT). Dr. Papaleontiou is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Debbie Chen is an Internal Medicine specialist and an Endocrinologist practicing medicine in Ann Arbor, Michigan. Dr. Chen is rated as an Advanced provider by MediFind in the treatment of Medullary Thyroid Carcinoma. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Thyroid Cancer, Follicular Thyroid Cancer, Papillary Thyroid Cancer, and Medullary Thyroid Carcinoma.

Liselle Douyon is an Internal Medicine specialist and an Endocrinologist practicing medicine in Ann Arbor, Michigan. Dr. Douyon is rated as an Advanced provider by MediFind in the treatment of Medullary Thyroid Carcinoma. She is also highly rated in 37 other conditions, according to our data. Her clinical expertise encompasses Postmenopausal Osteoporosis, Osteoporosis, Thyroid Nodule, and Juvenile Primary Osteoporosis.

Jeffrey Sanfield is an Internal Medicine provider practicing medicine in Ypsilanti, Michigan. Dr. Sanfield is rated as an Advanced provider by MediFind in the treatment of Medullary Thyroid Carcinoma. He is also highly rated in 38 other conditions, according to our data. His clinical expertise encompasses Type 1 Diabetes (T1D), Subacute Thyroiditis, Hypothyroidism, and Obesity in Children.

Anca Avram is an Endocrinologist practicing medicine in Ann Arbor, Michigan. Dr. Avram is rated as an Advanced provider by MediFind in the treatment of Medullary Thyroid Carcinoma. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Thyroid Cancer, Osteopenia, Melorheostosis with Osteopoikilosis, Melorheostosis, and Thyroidectomy.

Dr. Bodnar is the Assistant Chief of Endocrinology & Metabolism at Ann Arbor VA Health System. He is a graduate of the University of Michigan Medical School, and completed Internal Medicine Residency and Chief Residency, as well as his Fellowship in Endocrinology at Michigan Medicine. From 2014-2021 he was in private practice at Ann Arbor Endocrinology & Diabetes and was a Key Clinical Faculty Member in the St. Joseph Mercy Ann Arbor Internal Medicine Residency. Dr. Bodnar is rated as an Experienced provider by MediFind in the treatment of Medullary Thyroid Carcinoma. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), Osteoporosis, and Pituitary Tumor. Dr. Bodnar is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Dr. Else’s primary appointment is with the Division of Metabolism, Endocrinology and Diabetes. He received his MD degree from the University of Hamburg, Germany. He pursued his clinical training at the University of Hamburg (Residency: Internal Medicine) and the University of Michigan (Residency: Internal Medicine, Fellowship: Endocrinology). His main research interests are the genetics of endocrine tumors. Dr. Else’s clinical practice focuses on the care for patients with benign and malignant endocrine tumors, particularly pheochromocytoma, adrenocortical tumors and neuroendocrine tumors as well as accompanying hormone excess syndromes (e.g Cushing syndrome, primary aldosteronism). Dr. Else has a particular interest in taking care of patients with hereditary syndromes that predispose to the development of endocrine tumors (e.g. Multiple Endocrine Neoplasia (MEN) type 1, MEN2A & MEN2B, Hereditary Paraganglioma Syndrome). He attends the Multidisciplinary Endocrine Oncology Clinic, where patients with tumors receive diagnostic procedures and treatment. In addition he is part of the Cancer Genetics Clinic, which evaluates patients for hereditary syndromes and also facilitates regular exams and surveillance for patients at risk for endocrine tumors. Dr. Else is rated as an Experienced provider by MediFind in the treatment of Medullary Thyroid Carcinoma. He is also highly rated in 105 other conditions, according to our data. His clinical expertise encompasses Adrenal Cancer, Adrenocortical Carcinoma, Adrenal Gland Adenoma, Neuroendocrine Tumor, and Thyroidectomy. Dr. Else is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Gary D. Hammer, M.D., Ph.D. is Professor in Departments of InternalMedicine (MEND), Cell & Developmental Biology, and Molecular &Integrative Physiology. He currently serves as Director of EndocrineOncology Program in Rogel Cancer Center where he holds the MillieSchembechler Professorship in Adrenal Cancer. He is past Director ofCenter for Organogenesis: Stem Cells & Regenerative Medicine. He hasbrokered the recent renaissance of the current Michigan team of adrenalscientists that includes a who’s who in the study of adrenal disease.He received the UofM Jerome Conn Award for Outstanding Research inInternal Medicine, the Endocrine Society Edwin B. Astwood Award forOutstanding Research and is a member of ASCI and AAP. He has served innumerous leadership roles at UofM and in the public and private sectorsincluding recent tenure on Board of Scientific Advisors for NCI. He isthe editor of four textbooks including Pathophysiology of Disease: AnIntroduction to Clinical Medicine (McGraw Hilll), and the upcomingAdrenal Section Editor for Degroot’s Endocrinology (Elsevier). He hasserved in numerous capacities for the world’s largest endocrineorganization, the Endocrine Society including his most recent role asPresident of the Society (2020-2021). An Advisor to the CongressionalH.E.L.P. committee - he co-authored the 21st Century Cancer ALERT(Access to Life-Saving Early detection, Research and Treatment) Act’’ lintroduced in Congress in 2009. He has been catalyst for the formationof two international cooperative groups, most recently the A5 (AmericanAustralian Asian Adrenal Alliance) that leverages collaboration tosecure projects from Pharma and funding agencies across the spectrum ofadrenal diseases. He is a cofounder of two companies - MILLENDO andSLING THERAPEUTICS that focus on rare endocrine diseases. Dr. Hammer is rated as an Experienced provider by MediFind in the treatment of Medullary Thyroid Carcinoma. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Adrenal Cancer, Adrenocortical Carcinoma, Neuroblastoma, and Hereditary Neuroblastoma. Dr. Hammer is board certified in Endocrinology, Diabetes & Metabolism.

Ram Menon is a Pediatric Endocrinologist and a Pediatrics provider practicing medicine in Ann Arbor, Michigan. Dr. Menon is rated as an Experienced provider by MediFind in the treatment of Medullary Thyroid Carcinoma. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Type 1 Diabetes (T1D), Congenital Hypothyroidism, Short Stature (Growth Disorders), Pediatric Growth Hormone Deficiency, and Thyroidectomy. Dr. Menon is board certified in Pediatric Endocrinology.

Arqam Zia is an Endocrinologist practicing medicine in Canton, Michigan. He has been practicing medicine for over 30 years. Dr. Zia is rated as an Experienced provider by MediFind in the treatment of Medullary Thyroid Carcinoma. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Hyperparathyroidism, Addison's Disease, Secondary Adrenal Insufficiency, and Triple A Syndrome. Dr. Zia is board certified in American Board Of Internal Medicine. Dr. Zia is currently accepting new patients.

Zahrae Sandouk M.D., is a Clinical Assistant Professor, board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism and a graduate from Henry Ford Hospital and Cleveland Clinic who has an interest in Diabetes mellitus, Diabetes complications, Cystic Fibrosis related Diabetes, Pituitary disorders, Prolactinoma, Hypopituitarism, Thyroid disorders, Bone and calcium disorders, Adrenal and Osteoporosis. Also the medical director of the Endocrine Testing Unity at the University of Michigan where dynamic studies are performed and is also part of the Cystic Fibrosis multidisciplinary team. Dr. Sandouk is rated as an Experienced provider by MediFind in the treatment of Medullary Thyroid Carcinoma. She is also highly rated in 39 other conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Adrenal Insufficiency Pediatric, Type 2 Diabetes (T2D), and Thyroid Nodule. Dr. Sandouk is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Jennifer Franzese is an Internal Medicine specialist and an Endocrinologist practicing medicine in Ann Arbor, Michigan. Dr. Franzese is rated as an Experienced provider by MediFind in the treatment of Medullary Thyroid Carcinoma. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), Maturity Onset Diabetes of the Young, and Thyroid Nodule.